Literature DB >> 19148796

Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.

Laurence Maiden1.   

Abstract

BACKGROUND: Case reports have linked nonsteroidal antiinflammatory drugs (NSAIDs) to a variety of lesions in the small and large bowel including bleeding, protein loss, strictures, increased intestinal permeability, and NSAID enteropathy. We here review the use of wireless capsule endoscopy to quantitate and assess the nature of the small bowel damage caused by NSAIDs when taken short term and in patients on long-term NSAIDs and COX-2 inhibitors.
METHODS: Forty healthy volunteers underwent a baseline capsule endoscopy. After taking diclofenac slow-release 75 mg twice a day for a total of 14 days, both investigations were repeated. A further 120 patients on long-term NSAIDs (more than 3 months) and 40 on COX-2 inhibitors underwent a capsule endoscopy study. Sixty healthy patients acted as controls. Small bowel damage was categorized and quantitated.
RESULTS: Short-term diclofenac: Capsule endoscopy demonstrated new pathology in 27 (68%) of subjects. The most common lesions were mucosal breaks, seen in 16 (40%), which were seen to be bleeding in 2 (5%). Long-term NSAIDs: The main pathology was related to mucosal breaks (29%); 3% had free luminal blood and 2% had strictures. The damage seen in 50% of patients on selective COX-2 inhibitors did not differ significantly (P<0.5) from that seen with NSAIDs.
CONCLUSIONS: Capsule endoscopy demonstrates evidence of macroscopic injury to the small intestine, in up to 68% of volunteers, resulting from 2 weeks ingestion of slow-release diclofenac. Long-term use of NSAIDs and COX-2 inhibitors causes comparable small bowel damage (50%-68%).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148796     DOI: 10.1007/s00535-008-2248-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  48 in total

1.  Small bowel enteroscopy in undiagnosed gastrointestinal blood loss.

Authors:  A J Morris; L A Wasson; J F MacKenzie
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage.

Authors:  J G Ferraz; K A Sharkey; B K Reuter; S Asfaha; A W Tigley; M L Brown; W McKnight; J L Wallace
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

3.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

4.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

Review 5.  Cyclooxygenase-2 as a therapeutic target.

Authors:  J A Mitchell; T W Evans
Journal:  Inflamm Res       Date:  1998-10       Impact factor: 4.575

6.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

Authors:  R Langenbach; S G Morham; H F Tiano; C D Loftin; B I Ghanayem; P C Chulada; J F Mahler; C A Lee; E H Goulding; K D Kluckman; H S Kim; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

7.  COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.

Authors:  Gudmundur Sigthorsson; Robert J Simpson; Matthew Walley; Andrew Anthony; Russell Foster; Christoph Hotz-Behoftsitz; Abbas Palizban; Joaquim Pombo; Jo Watts; Scott G Morham; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

8.  Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models.

Authors:  J F Fries; C A Williams; D A Bloch; B A Michel
Journal:  Am J Med       Date:  1991-09       Impact factor: 4.965

9.  Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.

Authors:  I Bjarnason; P Williams; A So; G D Zanelli; A J Levi; J M Gumpel; T J Peters; B Ansell
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

10.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.

Authors:  Laurence Maiden; Bjarni Thjodleifsson; Anna Seigal; Ingvar Iain Bjarnason; David Scott; Sigurbjorn Birgisson; Ingvar Bjarnason
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

View more
  36 in total

Review 1.  Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.

Authors:  Sung Chul Park; Hoon Jai Chun; Chang Don Kang; Donggeun Sul
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

2.  Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.

Authors:  Chen Huang; Bin Lu; Yi-Hong Fan; Lu Zhang; Ning Jiang; Shuo Zhang; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  New vision in video capsule endoscopy: current status and future directions.

Authors:  Laurel R Fisher; William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

Review 4.  Present status and strategy of NSAIDs-induced small bowel injury.

Authors:  Kazuhide Higuchi; Eiji Umegaki; Toshio Watanabe; Yukiko Yoda; Eijiro Morita; Mitsuyuki Murano; Satoshi Tokioka; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

5.  Diaphragm disease compared with cryptogenic multifocal ulcerous stenosing enteritis.

Authors:  Sook Hee Chung; Yunju Jo; Sang Ryol Ryu; Sang Bong Ahn; Byoung Kwan Son; Seong Hwan Kim; Young Sook Park; Young Ok Hong
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 6.  NSAID enteropathy: could probiotics prevent it?

Authors:  Massimo Montalto; Antonella Gallo; Antonio Gasbarrini; Raffaele Landolfi
Journal:  J Gastroenterol       Date:  2012-08-09       Impact factor: 7.527

7.  Special diaphragm-like strictures of small bowel unrelated to non-steroidal anti-inflammatory drugs.

Authors:  Ming-Liang Wang; Fei Miao; Yong-Hua Tang; Xue-Song Zhao; Jie Zhong; Fei Yuan
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

8.  Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin-induced gastric injury.

Authors:  Chenchen Liu; Zhaotao Duan; Yue Guan; Hailu Wu; Kewei Hu; Xin Gao; Fangcen Yuan; Zongdan Jiang; Ye Fan; Bangshun He; Shukui Wang; Zhenyu Zhang
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

Review 9.  Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies.

Authors:  Urs A Boelsterli; Matthew R Redinbo; Kyle S Saitta
Journal:  Toxicol Sci       Date:  2012-10-22       Impact factor: 4.849

10.  In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.

Authors:  Yun Jeong Lim; Tri M Phan; Elizabeth J Dial; David Y Graham; Lenard M Lichtenberger
Journal:  Digestion       Date:  2012-08-14       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.